Cargando…

Antiviral effect of SARS-CoV-2 N-specific CD8(+) T cells induced in lungs by engineered extracellular vesicles

Induction of effective immunity in the lungs should be a requisite for any vaccine designed to control the severe pathogenic effects generated by respiratory infectious agents. We recently provided evidence that the generation of endogenous extracellular vesicles (EVs) engineered for the incorporati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manfredi, Francesco, Chiozzini, Chiara, Ferrantelli, Flavia, Leone, Patrizia, Pugliese, Katherina, Spada, Massimo, Di Virgilio, Antonio, Giovannelli, Andrea, Valeri, Mauro, Cara, Andrea, Michelini, Zuleika, Andreotti, Mauro, Federico, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237059/ https://www.ncbi.nlm.nih.gov/pubmed/37268624 http://dx.doi.org/10.1038/s41541-023-00686-y

Ejemplares similares

SARS-CoV-2-Specific CD8(+) T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
por: Ferrantelli, Flavia, et al.
Publicado: (2023)

Strong SARS-CoV-2 N-Specific CD8(+) T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
por: Ferrantelli, Flavia, et al.
Publicado: (2022)

Simultaneous CD8(+) T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
por: Ferrantelli, Flavia, et al.
Publicado: (2021)

Long-Term Antitumor CD8(+) T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
por: Ferrantelli, Flavia, et al.
Publicado: (2021)

The C-Terminal Domain of Nef(mut) Is Dispensable for the CD8(+) T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2021)

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
por: Manfredi, Francesco, et al.
Publicado: (2022)

Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
por: Ferrantelli, Flavia, et al.
Publicado: (2020)

N-Terminal Fatty Acids of NEF(MUT) Are Required for the CD8(+) T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2020)

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells
por: Ferrantelli, Flavia, et al.
Publicado: (2019)

Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting
por: Fiani, Maria Luisa, et al.
Publicado: (2020)

Nonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice
por: Negri, Donatella R. M., et al.
Publicado: (2010)

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
por: Di Bonito, Paola, et al.
Publicado: (2017)

HPV-E7 Delivered by Engineered Exosomes Elicits a Protective CD8(+) T Cell-Mediated Immune Response
por: Di Bonito, Paola, et al.
Publicado: (2015)

Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
por: Rossi, Alessandra, et al.
Publicado: (2014)

Erratum to: Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
por: Sabbatucci, Michela, et al.
Publicado: (2015)

Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
por: Sabbatucci, Michela, et al.
Publicado: (2015)

Extracellular Vesicles in Viral Spread and Antiviral Response
por: Bello-Morales, Raquel, et al.
Publicado: (2020)

Extracellular Vesicles Regulated by Viruses and Antiviral Strategies
por: Yang, Li, et al.
Publicado: (2021)

UltraViolet SANitizing System for Sterilization of Ambulances Fleets and for Real-Time Monitoring of Their Sterilization Level
por: Michelini, Zuleika, et al.
Publicado: (2021)

Intranasal Administration of Integrase Defective Lentiviral Vectors Expressing mAbs Protects from H5 Influenza Virus Challenge In Vivo
por: Michelini, Zuleika, et al.
Publicado: (2017)

Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis
por: Zarà, Marta, et al.
Publicado: (2019)

Extracellular Vesicles as Source of Biomarkers in Glomerulonephritis
por: Bruschi, Maurizio, et al.
Publicado: (2023)

Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
por: Fontana, Judith M., et al.
Publicado: (2014)

Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
por: Gallinaro, Alessandra, et al.
Publicado: (2020)

Proteomic and functional profiling of platelet-derived extracellular vesicles released under physiological or tumor-associated conditions
por: Vismara, Mauro, et al.
Publicado: (2022)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
por: Negri, Donatella RM, et al.
Publicado: (2012)

Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021)

Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization
por: Bona, Roberta, et al.
Publicado: (2021)

Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
por: Michelini, Zuleika, et al.
Publicado: (2020)

Cell activation and HIV-1 replication in unstimulated CD4(+) T lymphocytes ingesting exosomes from cells expressing defective HIV-1
por: Arenaccio, Claudia, et al.
Publicado: (2014)

Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency
por: Herrera Sanchez, Maria Beatriz, et al.
Publicado: (2017)

Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1
por: Arenaccio, Claudia, et al.
Publicado: (2015)

Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy
por: Jayasinghe, Migara K., et al.
Publicado: (2023)

Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
por: Mannavola, Francesco, et al.
Publicado: (2019)

Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context
por: Esmaeili, Abazar, et al.
Publicado: (2022)

Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19
por: Kumar, Santosh, et al.
Publicado: (2020)

Inhibiting Extracellular Vesicle Trafficking as Antiviral Approach to Corona Virus Disease 2019 Infection
por: Urciuoli, Enrica, et al.
Publicado: (2020)

The Role of Extracellular Vesicles in Bone Metastasis
por: Rossi, Michela, et al.
Publicado: (2018)

Emerging diversity in extracellular vesicles and their roles in cancer
por: Sohal, Ikjot S., et al.
Publicado: (2023)

A Perspective on Extracellular Vesicles Proteomics
por: Rosa-Fernandes, Livia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eurd9o3dok6kvnr09fmlo8d24n